Ekso Bionics Holdings Inc Revenue Growth Rates (EKSO), Current and Historic Growth - CSIMarket
CSIMarket
 


Ekso Bionics Holdings Inc   (NASDAQ: EKSO)
 

EKSO's Revenue Growth by Quarter and Year

Ekso Bionics Holdings Inc 's Revenue results by quarter and year




EKSO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 2.07
FY 2.07

EKSOs Annual Revenue
Ekso Bionics Holdings Inc 's Revenue in the fiscal year 2026 $ 84.38 millions
Ekso Bionics Holdings Inc 's Revenue in the fiscal year 2025 $ 11.85 millions
Ekso Bionics Holdings Inc 's Revenue in the fiscal year 2024 $ 17.51 millions
Ekso Bionics Holdings Inc 's Revenue in the fiscal year 2023 $ 18.08 millions
Ekso Bionics Holdings Inc 's Revenue in the fiscal year 2022 $ 12.91 millions




EKSO Revenue first quarter 2026 Y/Y Growth Comment
Ekso Bionics Holdings Inc reported fall in Revenue in the first quarter 2026 by -26.19% to $ 2.07 millions, from the same quarter in 2025.
The drop in the first quarter 2026 Ekso Bionics Holdings Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 46058.08%.

Looking into first quarter 2026 results within Industrial Machinery and Components industry 96 other companies have achieved higher Revenue growth. While Ekso Bionics Holdings Inc ' s Revenue drop of -26.19% ranks overall at the positon no. 3622 in the first quarter 2026.




EKSO Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - -45.31 % 39.79 % 35.21 %
3rd Quarter September - 10.59 % -28.03 % 33.93 %
2nd Quarter June - -60.78 % -1.28 % 35.45 %
1st Quarter March -26.19 % -4.75 % -28.4 % 60.31 %
FY   - -32.32 % -3.15 % -

Financial Statements
Ekso Bionics Holdings Inc 's first quarter 2026 Revenue $ 2.07 millions EKSO's Income Statement
Ekso Bionics Holdings Inc 's first quarter 2025 Revenue $ 2.81 millions Quarterly EKSO's Income Statement


EKSO Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 3.38 % 109.03 % 7.62 %
3rd Quarter September - 95.05 % -30.82 % -5.11 %
2nd Quarter June - -35.23 % 57.29 % 14.08 %
1st Quarter March -43.49 % -58.12 % -38.54 % 16.06 %
FY (Year on Year)   - -32.32 % -3.15 % -




Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Industrial Machinery and Components Industry #97
Capital Goods Sector #252
Overall #3622

Revenue Y/Y Growth Statistics
High Average Low
1603361.54 % 46058.08 % -83.08 %
(Sep 30 2018)   (Sep 30 2017)
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Industrial Machinery and Components Industry #97
Capital Goods Sector #252
Overall #3622
Revenue Y/Y Growth Statistics
High Average Low
1603361.54 % 46058.08 % -83.08 %
(Sep 30 2018)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Ekso Bionics Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
336.75 % 12.45 % -81.71 %
(Mar 31 2016)  


EKSO's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Ekso Bionics Holdings Inc disclosed fall in Revenue from the fourth quarter by -43.49% to $ 2.07 millions, from $ 3.67 millions achived in the previous reporting period.

But that's not important problem, as Ekso Bionics Holdings Inc 's Revenue generally seem to plunge in this quarter.

Within Industrial Machinery and Components industry 84 other companies have achieved higher Revenue quarter on quarter growth. While Ekso Bionics Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3147.


Revenue Q/Q Growth Company Ranking
Within: No.
Industrial Machinery and Components Industry #85
Capital Goods Sector #216
Overall #3147
Revenue Q/Q Growth Company Ranking
Within: No.
Industrial Machinery and Components Industry #85
Capital Goods Sector #216
Overall #3147
Revenue Q/Q Growth Statistics
High Average Low
336.75 % 12.45 % -81.71 %
(Mar 31 2016)  


EKSO's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Ekso Bionics Holdings Inc disclosed fall in Revenue from the fourth quarter by -43.49% to $ 2.07 millions, from $ 3.67 millions achived in the previous reporting period.

But that's not important problem, as Ekso Bionics Holdings Inc 's Revenue generally seem to plunge in this quarter.

Within Industrial Machinery and Components industry 84 other companies have achieved higher Revenue quarter on quarter growth. While Ekso Bionics Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3147.


Ekso Bionics Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 11.11 $ 11.84 $ 14.89 $ 14.55 $ 17.37
Y / Y Revenue Growth (TTM) -36.01 % -32.36 % -4.53 % -13.62 % 2.71 %
Year on Year Revenue Growth Overall Ranking # 1969 # 1091 # 1943 # 1306 # 654
Seqeuential Revenue Change (TTM) -6.18 % -20.44 % 2.34 % -16.23 % -0.83 %
Seq. Revenue Growth (TTM) Overall Ranking # 2273 # 359 # 1944 # 2121 # 2533


Cumulative Revenue growth Comment
Ekso Bionics Holdings Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -36.01% year on year, at Mar 31 2026 compare to the -32.36% decrease at Dec 31 2025. If the Ekso Bionics Holdings Inc 's fiscal year would end at Mar 31 2026, annual Revenue would be $11 millions.

In the Capital Goods sector 146 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1091 to 1969.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Industrial Machinery and Components Industry # 68
Capital Goods Sector # 147
Overall # 1969

Revenue TTM Y/Y Growth Statistics
High Average Low
498.63 %
45.76 %
-87.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 68
Sector # 163
S&P 500 # 2273
Cumulative Revenue growth Comment
Ekso Bionics Holdings Inc 's cumulative 12 months Revenue continue to drop, but on the faster rate at -36.01% year on year, at Mar 31 2026 compare to the -32.36% decrease at Dec 31 2025. If the Ekso Bionics Holdings Inc 's fiscal year would end at Mar 31 2026, annual Revenue would be $11 millions.

In the Capital Goods sector 146 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1091 to 1969.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Industrial Machinery and Components Industry # 68
Capital Goods Sector # 147
Overall # 1969

Revenue TTM Y/Y Growth Statistics
High Average Low
498.63 %
45.76 %
-87.1 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 68
Sector # 163
S&P 500 # 2273




Other Revenue Growth
Industrial Machinery and Components Industry Revenue Growth Trends and Statistics
Capital Goods Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EKSO's Revenue Growth Ratio versus Industrial Machinery and Components Industry, Capital Goods Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Mar 31 2026 within Capital Goods SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Cnh Industrial N v -0.05%$ -0.052 millions
Voyager Technologies Inc -0.15%$ -0.154 millions
Blue Bird Corporation-1.73%$ -1.735 millions
Connectm Technology Solutions Inc -1.86%$ -1.855 millions
Cricut Inc -2.25%$ -2.248 millions
D r Horton Inc -2.27%$ -2.274 millions
Energizer Holdings Inc -2.90%$ -2.900 millions
Nauticus Robotics Inc -3.44%$ -3.438 millions
Installed Building Products Inc -3.56%$ -3.564 millions
Legacy Housing Corporation-3.66%$ -3.656 millions
Air Industries Group-4.36%$ -4.359 millions
Fuel Tech Inc -4.73%$ -4.732 millions
Nextpower Inc -4.74%$ -4.741 millions
Onar Holding Corporation-4.80%$ -4.802 millions
Green Brick Partners Inc -4.87%$ -4.870 millions
Veeco Instruments Inc -5.19%$ -5.190 millions
Primoris Services Corporation-5.34%$ -5.338 millions
Chicago Rivet and Machine Co -5.44%$ -5.439 millions
Mi Homes Inc -5.67%$ -5.674 millions
Jbt Marel Corporation-6.48%$ -6.484 millions
Flowserve Corp-6.68%$ -6.684 millions
Ultralife Corporation-7.16%$ -7.163 millions
Freedom Acquisition I Corp-7.17%$ -7.167 millions
Fluor Corporation-8.01%$ -8.011 millions
Stem Inc -8.49%$ -8.495 millions
Smith Douglas Homes Corp -8.50%$ -8.497 millions
Lgi Homes Inc -9.02%$ -9.016 millions
Badger Meter Inc -9.08%$ -9.082 millions
Gencor Industries Inc -9.76%$ -9.758 millions
Dream Finders Homes Inc -10.31%$ -10.308 millions


About Ekso Bionics Holdings Inc Revenue Growth Rates (EKSO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Chronoscale Holdings Corp (CIK 1549084).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-058018
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Chronoscale Holdings Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.